Donna Stock-Novack

891 total citations
11 papers, 673 citations indexed

About

Donna Stock-Novack is a scholar working on Hematology, Pathology and Forensic Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Donna Stock-Novack has authored 11 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Pathology and Forensic Medicine and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Donna Stock-Novack's work include Multiple Myeloma Research and Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Donna Stock-Novack is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Chemotherapy-induced organ toxicity mitigation (3 papers). Donna Stock-Novack collaborates with scholars based in United States, Canada and South Africa. Donna Stock-Novack's co-authors include John Crowley, SE Salmon, BG Durie, Patrick R. Finley, Coltman Ca, Earl A. Surwit, David S. Alberts, Edward V. Hannigan, Robert V. O’Toole and Peter Anderson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Donna Stock-Novack

11 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donna Stock-Novack United States 10 249 246 181 179 154 11 673
Luigi Salvagno Italy 15 270 1.1× 121 0.5× 115 0.6× 43 0.2× 98 0.6× 46 618
J Chauvergne France 16 353 1.4× 40 0.2× 121 0.7× 132 0.7× 219 1.4× 107 833
A. Bamias Greece 11 226 0.9× 104 0.4× 207 1.1× 184 1.0× 130 0.8× 28 559
M.R. Sertoli Italy 15 432 1.7× 45 0.2× 120 0.7× 136 0.8× 92 0.6× 34 630
F Carnino Italy 17 439 1.8× 80 0.3× 70 0.4× 398 2.2× 257 1.7× 39 914
A.B.W. Nethersell United Kingdom 14 157 0.6× 70 0.3× 117 0.6× 45 0.3× 89 0.6× 30 523
Jeffrey Schneider United States 15 592 2.4× 139 0.6× 132 0.7× 62 0.3× 120 0.8× 40 882
M. R. Sertoli Italy 11 391 1.6× 98 0.4× 141 0.8× 87 0.5× 52 0.3× 26 638
J. F. Pringle Canada 18 480 1.9× 53 0.2× 155 0.9× 355 2.0× 363 2.4× 22 1.3k
M. Gropp Germany 10 232 0.9× 51 0.2× 96 0.5× 570 3.2× 346 2.2× 23 766

Countries citing papers authored by Donna Stock-Novack

Since Specialization
Citations

This map shows the geographic impact of Donna Stock-Novack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Stock-Novack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Stock-Novack more than expected).

Fields of papers citing papers by Donna Stock-Novack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Stock-Novack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Stock-Novack. The network helps show where Donna Stock-Novack may publish in the future.

Co-authorship network of co-authors of Donna Stock-Novack

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Stock-Novack. A scholar is included among the top collaborators of Donna Stock-Novack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Stock-Novack. Donna Stock-Novack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Fung, Anthony, Gerald Lorch, Patrick Cambier, et al.. (1999). Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. American Heart Journal. 138(4). 696–704. 13 indexed citations
3.
Gupta, V. D., E. Brad Thompson, Donna Stock-Novack, et al.. (1994). Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. Investigational New Drugs. 12(2). 121–128. 10 indexed citations
4.
Elias, Laurence, Donna Stock-Novack, David R. Head, et al.. (1993). A phase I trial of combination fludarabine monophosphate and chlorambucil in chronic lymphocytic leukemia: a Southwest Oncology Group study.. PubMed. 7(3). 361–5. 55 indexed citations
5.
Alberts, David S., Edward V. Hannigan, Robert V. O’Toole, et al.. (1992). Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.. Journal of Clinical Oncology. 10(5). 706–717. 225 indexed citations
6.
Alberts, David S., Stephanie Green, Edward V. Hannigan, et al.. (1992). Improved Therapeutic Index of Carboplatin Plus Cyclophosphamide Versus Cisplatin Plus Cyclophosphamide. Journal of Clinical Oncology. 10(9). 1505–1505. 1 indexed citations
7.
8.
Hoff, Daniel D. Von, Stephanie Green, David S. Alberts, et al.. (1991). Phase II Study of Fludarabine Phosphate (NSC-312887) in Patients with Advanced Endometrial Cancer. American Journal of Clinical Oncology. 14(3). 193–194. 12 indexed citations
9.
Durie, BG, Donna Stock-Novack, SE Salmon, et al.. (1990). Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]. Blood. 75(4). 823–830. 133 indexed citations
10.
Durie, BG, Donna Stock-Novack, SE Salmon, et al.. (1990). Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]. Blood. 75(4). 823–830. 126 indexed citations
11.
Alberts, David S., Richard A. Kronmal, Lawrence Baker, et al.. (1987). Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.. Journal of Clinical Oncology. 5(11). 1791–1795. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Salvagno Breakdown of academic impact, for papers by J Chauvergne Breakdown of academic impact, for papers by A. Bamias Breakdown of academic impact, for papers by M.R. Sertoli Breakdown of academic impact, for papers by F Carnino Breakdown of academic impact, for papers by A.B.W. Nethersell Breakdown of academic impact, for papers by Jeffrey Schneider Breakdown of academic impact, for papers by M. R. Sertoli Breakdown of academic impact, for papers by J. F. Pringle Breakdown of academic impact, for papers by M. Gropp
Rankless by CCL
2026